Approach Differs In The United Kingdom And Europe

In the United Kingdom, the CSM issued a "Dear Healthcare Professional'' letter regarding the evidence of a link between phenylpropanolamine and stroke.829:2 After conducting an initial review, the CSM concluded that the evidence for the link was weak and mainly associated with indications which are not licensed in the United Kingdom. European regulatory authorities are taking a similar approach as in the United Kingdom.831:2 Statements have been issued by all European authorities advising that all phenylpropanola-mine-containing products should remain on the market pending a review of the situation.

Was this article helpful?

0 0
Drug Free Life

Drug Free Life

How To Beat Drugs And Be On Your Way To Full Recovery. In this book, you will learn all about: Background Info On Drugs, Psychological Treatments Statistics, Rehab, Hypnosis and Much MORE.

Get My Free Ebook

Post a comment